Support for new S3 listing

Pharmacy Guild and other groups voice support for a new Schedule 3 listing for celecoxib The Pharmacy Guild of Australia and other peak health stakeholder groups have supported a decision to create a new Schedule 3 category for the NSAID celecoxib. The March 2023 meeting of the Therapeutic Goods Administration's Advisory Committee on Medicines Scheduling